If Your Advantage Plan Ends December 31 and You Do Nothing, You Wake Up January 1 in Original Medicare With No Drug Coverage and No Medigap.
Humana (HUM) is ending Medicare Advantage plans for about 600,000 members in 2027. Affected members will revert to Original Medicare, which has a $1,736 Part A deductible and no annual out-of-pocket cap. They must act by December 31 to secure new coverage or face gaps in drug coverage and potential penalties. Medigap enrollment has a limited window for guaranteed issue rights.
How this was made
The 30-second read
Why it matters
The enrollment drop may pressure Humana's earnings guidance and share price in the coming quarters.
Market read
The news is relevant for investors in Humana and other Medicare Advantage insurers.
What to watch
Potential upside from new standalone Part D or Medigap sales to displaced members.
Background
Humana announced non‑renewal of certain Medicare Advantage plans for 2027, affecting ~600k members.
Ticker impact
Humana is pulling Medicare Advantage plans covering roughly 600,000 members for 2027 and will send non‑renewal letters in early October.
Potential short‑term downside of 2‑4% if the market prices in enrollment loss.
Enrollment loss is material for Humana's top line, but the exact financial impact is uncertain until the SEC filings.
Market effects
Other Medicare Advantage providers may see enrollment pressure as members seek alternatives.
U.S. health‑care insurers could experience modest enrollment shifts in the Medicare market.
Limited; primarily affects U.S. health‑care sector.
Counterpoint
The plan pull could free Humana to focus on higher‑margin products, mitigating revenue loss.
Key entities
- CompanyHumana Inc.
U.S. health‑care insurer offering Medicare Advantage plans.
